Cipla | CIPLA - Equity Capital And Reserves


Cipla reported INR344.32B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Arca Biopharma USD 486.72M 17.72M Mar/2026
aTyr Pharma USD 57.93M 82.05M Mar/2026
Bio Path USD -8.49M 482K Mar/2026
Brainstorm Cell Therapeutics USD -11.01M 1.02M Mar/2026
Capricor Therapeutics USD 278.7M 27.09M Mar/2026
Cara Therapeutics USD 20.95M 6.92M Dec/2025
Cipla INR 344.32B 15.13B Mar/2026
Dr.Reddys Laboratories INR 378.92B 3.16B Mar/2026
Esperion Therapeutics USD -307.93M 5.97M Mar/2026
Immunic USD 151.23M 157.91M Mar/2026
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
TherapeuticsMD USD 27.67M 990K Jun/2024
UPL INR 346.96B 28.02B Mar/2026